Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

May 31, 2010

Study Completion Date

May 31, 2010

Conditions
Major Depressive DisorderAlcohol AbuseAlcohol Dependence
Interventions
DRUG

acamprosate

Acamprosate 333mg, 2 capsules by mouth (i.e., PO), three times per day (i.e., TID), for 12 weeks.

DRUG

escitalopram

Escitalopram is given for 12 weeks. Dosing is flexible, starting at 10mg PO once per day (i.e., QD) with the possibility of increasing to 30mg PO QD.

BEHAVIORAL

Medical management

Based on the COMBINE study. 1 hour of medical management / behavioral intervention at every study visit (7 times over 12 weeks).

DRUG

Placebo

Placebo, 2 capsules PO TID, for 12 weeks

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

National Alliance for Research on Schizophrenia and Depression

OTHER

lead

Massachusetts General Hospital

OTHER

NCT00452543 - Acamprosate Added to Escitalopram and Behavioral Treatment for Comorbid Depression and Alcoholism | Biotech Hunter | Biotech Hunter